Impulsivity and its Therapeutic Management in Borderline Personality Disorder: a Systematic Review

被引:17
作者
Mungo, Anais [1 ]
Hein, Matthieu [1 ]
Hubain, Philippe [1 ]
Loas, Gwenole [1 ]
Fontaine, Philippe [2 ]
机构
[1] Univ Libre Bruxelles, Erasme Hosp, Dept Psychiat & Sleep Lab, Route Lennik 808, B-1070 Brussels, Belgium
[2] CHC Liege Site St Vincent, Dept Psychiat, Rocourt, Belgium
关键词
Borderline personality disorder; Impulsivity; Psychotherapy; Pharmacotherapy; Systematic review; DIALECTICAL BEHAVIOR-THERAPY; MENTALIZATION-BASED TREATMENT; DOUBLE-BLIND; FOLLOW-UP; RANDOMIZED-TRIAL; OPEN-LABEL; INTERPERSONAL PSYCHOTHERAPY; COGNITIVE THERAPY; DIVALPROEX SODIUM; EXTENDED-RELEASE;
D O I
10.1007/s11126-020-09845-z
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
No treatment has been approved and recognized as effective in borderline personality disorder (BPD). Impulsivity is a key dimension because it is a predictor of remission but also suicide. The purpose of this review is to establish an inventory on the management of impulsivity in BPD and determine the effective treatments. A systematic review on the PubMed and Ovid databases was conducted up to September 2019 to December 2019 using the PRISMA guidelines. The inclusion criteria were: studies with patients with borderline personality disorder, were published between 1989 and 2019, used English-language and evaluated impulsivity before and after treatment. 41 articles selected were included for pharmacological treatment. 24 articles were found for psychotherapeutic management and one randomized study of transcranial magnetic stimulation. Based on this review, we must focus on psychotherapy in BPD, particularly the schema therapy, dialectical behavioral therapy, psychoeducation, system training of emotional predictability and problem solving and psychotherapy using mentalisation. The use of neuroleptics and mood stabilizers appears to be more effective than antidepressants. Another approach, such as transcranial magnetic stimulation, may prove useful in the near future if this technique is studied further.
引用
收藏
页码:1333 / 1362
页数:30
相关论文
共 82 条
[1]   Quetiapine in Patients with Borderline Personality Disorder: An Open-Label Trial [J].
Adityanjee ;
Romine, Ann ;
Brown, Eric ;
Thuras, Paul ;
Lee, Susanne ;
Schulz, S. Charles .
ANNALS OF CLINICAL PSYCHIATRY, 2008, 20 (04) :219-226
[2]  
American Psychiatric Association, 2015, DSM 5 MANUEL DIAGNOS, V5
[3]  
[Anonymous], 2012, CLIN PRACTICE GUIDEL
[4]   8-year follow-up of patients treated for borderline personality disorder: Mentalization-based treatment versus treatment as usual [J].
Bateman, Anthony ;
Fonagy, Peter .
AMERICAN JOURNAL OF PSYCHIATRY, 2008, 165 (05) :631-638
[5]   Oxcarbazepine in the treatment of borderline personality disorder: A pilot study [J].
Bellino, S ;
Paradiso, E ;
Bogetto, F .
JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (09) :1111-1115
[6]   Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study [J].
Bellino, S. ;
Paradiso, E. ;
Bozzatello, P. ;
Bogetto, F. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (03) :333-339
[7]   Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study [J].
Bellino, Silvio ;
Paradiso, Erika ;
Bogetto, Filippo .
JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (07) :1042-1046
[8]  
Bellino Silvio, 2011, Depress Res Treat, V2011, P680194, DOI 10.1155/2011/680194
[9]   Adaptation of Interpersonal Psychotherapy to Borderline Personality Disorder: A Comparison of Combined Therapy and Single Pharmacotherapy [J].
Bellino, Silvio ;
Rinaldi, Camilla ;
Bogetto, Filippo .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2010, 55 (02) :74-81
[10]   Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder [J].
Bellino, Silvio ;
Paradiso, Erika ;
Bogetto, Filippo .
PSYCHIATRY RESEARCH, 2008, 161 (02) :206-212